Abstract

The prospective study is to investigate the associations between serum testosterone levels and LUTS among middle-aged men ≥40 years receiving health check-up. Lower urinary tract symptoms were evaluated by the self-administered International Prostate Symptom Score questionnaire. Serum prostate specific antigen and total testosterone level were checked in all subjects. A total of 1752 men were enrolled into the study. The mean age was 55.6 ± 9.7 years. All study subjects were stratified into low, medium and high testosterone levels by two cut-off, 3.0 and 4.11 ng/mL. We found that testosterone levels were significantly associated with metabolic syndrome and body fat components. Compared to those with low testosterone levels, subjects with high and medium testosterone had a significantly higher IPSS (5.84 ± 5.55 vs 6.71 ± 5.68 and 6.34 ± 5.66, p = 0.032) and storage score (2.76 ± 2.29 vs 3.20 ± 2.49 and 2.90 ± 2.49; p = 0.009), and a more moderate/severe LUTS (IPSS ≧ 8) (26.5% vs 35.7% and 29.9%; p = 0.002). Multivariate analyses showed that high vs low testosterone levels (OR, 1.76; 95% CI, 1.26–2.45) and prostate volume ≧25 vs <25 mL (OR, 1.38; 95% CI, 1.04–1.82) significantly associated with the presence of moderate/severe LUTS. Pearson correlation analyses showed significantly positive correlations between testosterone level and IPSS in whole study sample (Pearson correlation coefficient, 0.066; p < 0.01) and in the subgroup of moderate/severe LUTS (Pearson correlation coefficient, 0.038; p < 0.05). In conclusion, high testosterone and prostate volume adversely impacted LUTS in our target population.

Highlights

  • To date, the correlation between LUTS and testosterone in middle-aged men remains controversial

  • The testosterone levels (OR, 1.54; 95% CI, 1.20–1.99), age ≧ 53 vs.

  • Our results show that larger prostate volume and high testosterone levels were significantly associated with moderate/severe LUTS (IPSS ≧ 8) in our target male population

Read more

Summary

Introduction

The correlation between LUTS and testosterone in middle-aged men remains controversial. Emerging evidence indicate a positive correlation between testosterone and LUTS in men[3]. Crawford et al indicated that worsening of LUTS following testosterone replacement therapy in hypogonadal men may be due to stimulation of prostatic cells previously deprived of testosterone[5]. One systemic review reported that testosterone is not independently associated with either the pathogenesis or severity of LUTS8. Another study demonstrated that the impact of testosterone replacement therapy on LUTS were similar to the placebo effect[9]. Since there existed discrepancies about the impact of testosterone level on LUTS, we sought to clarify the associations between serum testosterone level and LTUS in in middle-aged men

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call